Executive Summary
This case involves Sanofi - Aventis challenging decisions related to its patent application (OA/11/2019/Pt/Kol). The matter was transferred from the Intellectual Property Appellate Board (IPAB) following the implementation of the Tribunals Reform Act, 2021. The Calcutta High Court directed the Commercial Appellate Division to issue necessary notices and file a report before proceeding with the hearing.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court. Understanding the court's reasoning in Sanofi - Aventis vs Controller General Of Patents, Designs and Trademarks And Anr. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Sun Pharma Laboratories Ltd.vsMicrocosm Pharma & Ors.
In a trademark infringement suit, Sun Pharma Laboratories Ltd. filed a claim against Microcosm Pharma regarding the alleged deceptive similarity between its registered mark 'PEGMOVE' and the defendant's mark 'PEG-MU'. During court proceedings, the proprietor of Defendant No. 1 voluntarily offered to discontinue the use of the impugned mark and undertake not to adopt any similar marks. While the suit continues for formal registration and issue framing, this offer suggests a potential path toward an amicable resolution.
Lg Electronics India Pvt. Ltd.vsBharat Bhogilal Patel & Others
LG Electronics filed a suit challenging actions taken by Customs officials (Defendants No. 2 and 3) who were restricting the clearance of its goods based on a patent infringement complaint filed by Defendant No. 1. The plaintiff argued that the impugned patent lacked novelty and inventive step, and that Customs action was contrary to government circulars regarding border measures for patents.
Malikie Innovations Ltd & AnrvsXiaomi Corporation & Ors
Malikie Innovations Ltd filed a suit against Xiaomi Corporation seeking restraining orders against infringing their Standard Essential Patents (SEPs), which are incorporated into 4G and 5G cellular standards. The Plaintiffs also seek damages and declarations regarding FRAND compliance. The court allowed various interlocutory applications, including leave to amend claims and grant temporary injunctions.
Danone And Pacific Holdings Pte LtdvsAlvo Life Sciences And Ors & Ors
The Delhi High Court addressed a complex trademark infringement suit involving Danone And Pacific Holdings and Alvo Life Sciences. The court formally decreed the suit against defendants 1 through 7 based on a previously executed Memorandum of Compromise, which included payments and undertakings to cease infringing use. Furthermore, the court accepted an offer from defendant 11 to settle the dispute, directing them to deposit damages, thereby facilitating a resolution for all parties involved.
M/S Gufic Biosciences LimitedvsM/S Saarvasri Herbs Private Limited And Ors
The Delhi High Court approved an amicable settlement between the Plaintiff, M/S Gufic Biosciences Limited, and Defendant No. 1, M/S Saarvasri Herbs Private Limited. Under the settlement, Defendant No. 1 acknowledged the exclusive rights to the 'SALLAKI' trademark and agreed to permanently cease using any similar marks or packaging. Furthermore, the court granted the Plaintiff permission to delete Defendants 2 and 3 from the suit, allowing them to pursue separate legal actions against those parties.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.